Gemma E. Hartley

471 total citations
6 papers, 230 citations indexed

About

Gemma E. Hartley is a scholar working on Infectious Diseases, Immunology and Oncology. According to data from OpenAlex, Gemma E. Hartley has authored 6 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Immunology and 3 papers in Oncology. Recurrent topics in Gemma E. Hartley's work include SARS-CoV-2 and COVID-19 Research (5 papers), T-cell and B-cell Immunology (2 papers) and CAR-T cell therapy research (2 papers). Gemma E. Hartley is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), T-cell and B-cell Immunology (2 papers) and CAR-T cell therapy research (2 papers). Gemma E. Hartley collaborates with scholars based in Australia, United States and Netherlands. Gemma E. Hartley's co-authors include Menno C. van Zelm, Emily S.J. Edwards, Robyn E. O’Hehir, P. Mark Hogarth, Heidi E. Drummer, Irene Boo, Nirupama Varese, James McMahon, Stephanie Stojanovic and Pei M. Aui and has published in prestigious journals such as Allergy, Biochemical Society Transactions and Journal of Clinical Immunology.

In The Last Decade

Gemma E. Hartley

6 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gemma E. Hartley Australia 6 198 79 46 26 23 6 230
Laura Thümmler Germany 8 254 1.3× 52 0.7× 76 1.7× 26 1.0× 24 1.0× 16 293
Stephanie Stojanovic Australia 4 160 0.8× 51 0.6× 43 0.9× 19 0.7× 23 1.0× 9 238
Ludwig Knabl Austria 10 206 1.0× 54 0.7× 30 0.7× 54 2.1× 22 1.0× 21 254
Marshall Lammers United States 3 166 0.8× 61 0.8× 25 0.5× 50 1.9× 20 0.9× 5 202
Cindy Wu United States 2 259 1.3× 73 0.9× 34 0.7× 60 2.3× 24 1.0× 3 289
David X. Lee United States 5 272 1.4× 49 0.6× 28 0.6× 28 1.1× 36 1.6× 7 287
Ida Jarlhelt Denmark 11 218 1.1× 50 0.6× 45 1.0× 88 3.4× 23 1.0× 15 319
Wanda Christ Sweden 11 187 0.9× 92 1.2× 36 0.8× 38 1.5× 6 0.3× 17 272
Chengzi I. Kaku United States 7 230 1.2× 93 1.2× 29 0.6× 52 2.0× 14 0.6× 9 276
Jacob Kinskey United States 4 107 0.5× 34 0.4× 27 0.6× 34 1.3× 18 0.8× 7 172

Countries citing papers authored by Gemma E. Hartley

Since Specialization
Citations

This map shows the geographic impact of Gemma E. Hartley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma E. Hartley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma E. Hartley more than expected).

Fields of papers citing papers by Gemma E. Hartley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gemma E. Hartley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma E. Hartley. The network helps show where Gemma E. Hartley may publish in the future.

Co-authorship network of co-authors of Gemma E. Hartley

This figure shows the co-authorship network connecting the top 25 collaborators of Gemma E. Hartley. A scholar is included among the top collaborators of Gemma E. Hartley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gemma E. Hartley. Gemma E. Hartley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Hartley, Gemma E., Paul A. Gill, Irene Boo, et al.. (2024). Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding. npj Vaccines. 9(1). 129–129. 8 indexed citations
2.
Hartley, Gemma E., Emily S.J. Edwards, Nirupama Varese, et al.. (2023). COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants. Journal of Clinical Immunology. 43(7). 1506–1518. 10 indexed citations
3.
Hartley, Gemma E., Emily S.J. Edwards, Robyn E. O’Hehir, & Menno C. van Zelm. (2022). New insights into human immune memory from SARS‐CoV‐2 infection and vaccination. Allergy. 77(12). 3553–3566. 9 indexed citations
4.
Hartley, Gemma E., et al.. (2022). Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination. Biochemical Society Transactions. 50(6). 1643–1658. 11 indexed citations
5.
Hartley, Gemma E., Emily S.J. Edwards, Julian J. Bosco, et al.. (2020). Influenza‐specific IgG1+ memory B‐cell numbers increase upon booster vaccination in healthy adults but not in patients with predominantly antibody deficiency. Clinical & Translational Immunology. 9(10). e1199–e1199. 12 indexed citations
6.
Hartley, Gemma E., Emily S.J. Edwards, Pei M. Aui, et al.. (2020). Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence. Science Immunology. 5(54). 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026